Skip to content

BIONIK LABORATORIES CORP.: 10-Q filed 2021-11-10

What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2021-11-10 (fiscal Q2 2022): 46 published measures, 128 facts as tagged in accession 0001104659-21-136632.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-10
Fiscal period
fiscal Q2 2022
Accession
0001104659-21-136632 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3012,462,094USD
At 2021-03-318,786,085USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3010,124,562USD
At 2021-03-315,505,055USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-302,337,532USD
At 2021-03-313,281,030USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-304,774,663USD
At 2021-03-31608,348USD
At 2020-09-301,350,627USD
At 2020-03-312,269,747USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,267,989USD92
2021-04-01 to 2021-09-30-1,718,901USD183
2020-07-01 to 2020-09-30-1,627,622USD92
2020-04-01 to 2020-09-30-3,634,698USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-04-01 to 2021-09-30-1,375,798USD183
2020-04-01 to 2020-09-30-2,881,607USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-04-01 to 2021-09-300USD183
2020-04-01 to 2020-09-300USD183

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-30227,905USD92
2021-04-01 to 2021-09-30899,188USD183
2020-07-01 to 2020-09-30292,381USD92
2020-04-01 to 2020-09-30550,289USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-04-01 to 2021-09-305,550,000USD183
2020-04-01 to 2020-09-301,962,487USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-04-01 to 2021-09-300USD183
2020-04-01 to 2020-09-300USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-86,713,228USD
At 2021-03-31-84,994,327USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,855,512shares92
2021-04-01 to 2021-09-305,779,076shares183
2020-07-01 to 2020-09-305,126,834shares92
2020-04-01 to 2020-09-305,126,834shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,855,512shares92
2021-04-01 to 2021-09-305,779,076shares183
2020-07-01 to 2020-09-305,126,834shares92
2020-04-01 to 2020-09-305,126,834shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.22USD/shares92
2021-04-01 to 2021-09-30-0.3USD/shares183
2020-07-01 to 2020-09-30-0.32USD/shares92
2020-04-01 to 2020-09-30-0.71USD/shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.22USD/shares92
2021-04-01 to 2021-09-30-0.3USD/shares183
2020-07-01 to 2020-09-30-0.32USD/shares92
2020-04-01 to 2020-09-30-0.71USD/shares183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-3057,570USD
At 2021-03-3193,577USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,041,582USD92
2021-04-01 to 2021-09-30-1,843,467USD183
2020-07-01 to 2020-09-30-1,543,407USD92
2020-04-01 to 2020-09-30-3,501,943USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-307,184,269USD
At 2021-03-313,432,973USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-30225,184USD92
2021-04-01 to 2021-09-30327,480USD183
2020-07-01 to 2020-09-30111,408USD92
2020-04-01 to 2020-09-30186,383USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-309,844,499USD
At 2021-03-314,095,164USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30377,908USD
At 2021-03-31454,809USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-09-304,282,984USD
At 2021-03-314,282,984USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-3071,470USD
At 2021-03-31451,905USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,188,565USD92
2021-04-01 to 2021-09-302,531,226USD183
2020-07-01 to 2020-09-301,765,741USD92
2020-04-01 to 2020-09-303,919,630USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-30788,871USD
At 2021-03-31692,163USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30146,983USD92
2021-04-01 to 2021-09-30687,759USD183
2020-07-01 to 2020-09-30222,334USD92
2020-04-01 to 2020-09-30417,687USD183

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-3080,922USD92
2021-04-01 to 2021-09-30211,429USD183
2020-07-01 to 2020-09-3070,047USD92
2020-04-01 to 2020-09-30132,602USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-3085,085USD92
2021-04-01 to 2021-09-30266,052USD183
2020-07-01 to 2020-09-30419,606USD92
2020-04-01 to 2020-09-30803,826USD183

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3089,016,953USD
At 2021-03-3188,227,506USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-3027,904USD
At 2021-03-3142,149USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-30632,050USD
At 2021-03-31679,135USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-30574,480USD
At 2021-03-31585,558USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-30937,271USD
At 2021-03-31976,551USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-30779,901USD
At 2021-03-31760,026USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-301,549,265USD
At 2021-03-311,680,557USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2021-09-30195,063USD
At 2021-03-31268,083USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-04-01 to 2021-09-30-1,718,901USD183
2020-04-01 to 2020-09-30-3,634,698USD183

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,274,436USD92
2021-04-01 to 2021-09-30-1,733,146USD183
2020-07-01 to 2020-09-30-1,627,622USD92
2020-04-01 to 2020-09-30-3,634,698USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30664,523USD92
2021-04-01 to 2021-09-301,496,744USD183
2020-07-01 to 2020-09-301,090,379USD92
2020-04-01 to 2020-09-302,620,883USD183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-07-01 to 2021-09-3011,000USD92
2021-04-01 to 2021-09-3020,000USD183
2020-07-01 to 2020-09-3016,000USD92
2020-04-01 to 2020-09-3034,000USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-04-01 to 2021-09-3059,039USD183
2020-04-01 to 2020-09-3081,239USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-07-01 to 2021-09-3019,000USD92
2021-04-01 to 2021-09-301,563,840USD183
2020-04-01 to 2021-03-311,524,560USD365
2020-07-01 to 2020-09-3023,000USD92

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-226,407USD92
2021-04-01 to 2021-09-30124,566USD183
2020-07-01 to 2020-09-30-84,215USD92
2020-04-01 to 2020-09-30-132,755USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-09-30-380,435USD183
2020-04-01 to 2020-09-30-189,349USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-09-3096,708USD183
2020-04-01 to 2020-09-30-169,141USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-09-30-76,009USD183
2020-04-01 to 2020-09-30-327,475USD183

Inspect the source

Entity
BIONIK LABORATORIES CORP. / CIK 0001508381
Captured
SEC response SHA-256
5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))